Brief: Kazia Therapeutics Establishes 'At-The-Market' Equity Program With Oppenheimer & Co
26/04/2022 01:26
April 26 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* ESTABLISHMENT OF AN 'AT-THE-MARKET' EQUITY PROGRAM WITH
OPPENHEIMER & CO
* UNDER ATM, KAZIA MAY OFFER AND SELL VIA OPPENHEIMER UP TO
US$35
MLN OF ITS ORDINARY SHARES IN FORM OF ADSS
Source text for Eikon: ID:nASX24DPF3
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt